Altimmune, Inc. (ALT)
NASDAQ: ALT · Real-Time Price · USD
7.71
+0.52 (7.23%)
At close: Jun 25, 2025, 4:00 PM
3.900
-3.810 (-49.42%)
Pre-market: Jun 26, 2025, 7:18 AM EDT
Altimmune Employees
Altimmune had 59 employees as of December 31, 2024. The number of employees did not change compared to the previous year.
Employees
59
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$339
Profits / Employee
-$1,529,492
Market Cap
625.33M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
ALT News
- 12 hours ago - Altimmune to Announce Topline 24 Week Results from its IMPACT Phase 2b Trial of Pemvidutide in the Treatment of MASH on Thursday, June 26 - GlobeNewsWire
- 12 days ago - Altimmune Announces Multiple Presentations at Upcoming American Diabetes Association's Scientific Sessions - GlobeNewsWire
- 23 days ago - Altimmune Vs. Viking Therapeutics: Evaluating Pipeline Maturity, And Takeover Potential - Seeking Alpha
- 27 days ago - Altimmune: Upcoming MASH Data Could Be High Impact For Business Development Activity - Seeking Alpha
- 5 weeks ago - Altimmune Announces Initiation of RECLAIM Phase 2 Trial Evaluating the Efficacy and Safety of Pemvidutide in Alcohol Use Disorder (AUD) - GlobeNewsWire
- 6 weeks ago - Altimmune to Participate at Two Upcoming Investor Conferences - GlobeNewsWire
- 6 weeks ago - Altimmune, Inc. (ALT) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 6 weeks ago - Altimmune Announces First Quarter 2025 Financial Results and Business Update - GlobeNewsWire